Ambrisentan-Mepha 10 mg, Lactab

7680672940021 CH-67294 Tabletten

Associated product:

AMBRISENTAN Mepha Lactab 10 mg 30 pce
Ambrisentan-Mepha 10 mg, Lactab
Ambrisentan-Mepha 10 mg, Lactab
Ambrisentan-Mepha 10 mg, Lactab
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/08/2023
Patient information leaflet
Français
09/08/2023
Patient information leaflet
Italien
09/08/2023
Summary of Product Characteristics
Allemand
09/08/2023
Summary of Product Characteristics
Français
09/08/2023
Summary of Product Characteristics
Italien
09/08/2023

Detailed composition

Substance Quantity Type Category
FTAB
10.0 MG Substance Wirkstoff (Principe actif)
FTAB
150.0 MG Substance HBESI
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
0.22 MG Substance HBESI
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FNIDK

Reimbursement information

Public price
CHF 1093.70
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/02/2021

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
67294
Drug name
Ambrisentan-Mepha, Lactab
Galenic form
TAB
ATC Code
C02KX02
Authorization status
Z
Dispensing category
B
First authorization
27/10/2020
Authorization expiration date
31/12/9999
IT Number
02.07.1.
Domain
Human medicine
Field of application
Pulmonale arterielle Hypertonie

Package details

Description (FR)
AMBRISENTAN Mepha Lactab 10 mg 30 pce
Description (DE)
AMBRISENTAN Mepha Lactab 10 mg 30 Stk
Market launch
27/10/2020
Narcotic (BTM)
No

Original drug

Volibris, Filmtabletten
GTIN: 7680586540010
CHF 1195.35
View original

Other package sizes (1)

AMBRISENTAN Mepha Lactab 5 mg 30 pce
30 TABL
GTIN: 7680672940014
View